The Royal Marsden Hospital: Cancer Care in London

Zusammenfassung

Founded in 1851, The Royal Marsden is recognised as the world's first hospital dedicated to cancer diagnosis, treatment, research and education. It treats a broad range of adult cancers and has specialist children's and young people's services, whose current arrangements should be checked before referral. Breast, lung, prostate and colorectal cancers, sarcomas and blood cancers are among its established areas of care. Treatment planning is multidisciplinary and linked to research through its partnership with The Institute of Cancer Research. Its clinical trials portfolio is often described as around 300 studies, an indicative rather than live recruitment figure. Overseas patients should obtain a records review, proposed care plan and written funding information before making travel commitments.

Das Wichtigste

The Royal Marsden is a specialist cancer hospital with main sites in Chelsea and Sutton.
Its partnership with The Institute of Cancer Research supports laboratory research, clinical trials and drug development.
International patients can request assessment through its private care division.
Treatment recommendations depend on diagnosis, stage, previous treatment, molecular findings and fitness.
An indicative portfolio of around 300 oncology trials does not mean every study is recruiting.
Proton therapy should not be assumed to be an on-site Royal Marsden treatment.

Überblick

The Royal Marsden opened in 1851 as the Free Cancer Hospital. It is recognised as the first hospital in the world dedicated to cancer. Today, The Royal Marsden NHS Foundation Trust provides specialist cancer services alongside private care, including care for patients travelling from overseas.

Its main hospital campuses are in Chelsea and Sutton. These form a substantial specialist service rather than a single-site clinic, with inpatient, outpatient, diagnostic and treatment facilities. The appropriate location depends on the disease team and procedure; patients should confirm where each part of their assessment and treatment would take place.

The hospital's partnership with The Institute of Cancer Research connects clinical care with cancer biology, molecular diagnostics and treatment development. It is particularly known for early-phase research and a substantial drug development unit. Specialist teams discuss cases across disciplines, although access to a particular team, technology or experimental treatment requires individual assessment.

Schwerpunkte

Established programmes include breast, lung, prostate and colorectal cancers, including colon cancer. Care may involve diagnostic review, staging, surgery, radiotherapy and systemic treatment. For some cancers, molecular or genetic testing helps identify suitable medicines or trials. The relevance of these tests depends on the tumour type, disease stage and previous testing; not every patient needs a broad genomic panel.

The centre also treats sarcomas and blood cancers, where specialist pathology and disease-specific expertise can be important. Children's and young people's cancer services have historically been based at Sutton, with access to age-specific support and treatment programmes. Families should confirm the current provider, site and age criteria before arranging a referral, as regional paediatric service arrangements can change. Specialist service availability is not evidence that one hospital will achieve better outcomes for every patient.

Verfügbare Behandlungen

Cancer surgery is offered through specialist teams, with the approach determined by tumour location, extent and the patient's overall health. Assessment may include review of imaging and pathology before an operation is recommended. Some patients need treatment before or after surgery; others may be advised against an operation if its risks outweigh the likely benefit.

Systemic treatments include chemotherapy, hormone therapy, targeted therapy and immunotherapy where appropriate. Targeted medicines often require a relevant molecular finding, while immunotherapy is useful only in particular clinical settings. Availability depends on the indication, authorisation, funding and whether treatment is standard care or part of a trial. These treatments can cause serious adverse effects and require monitoring.

Radiotherapy is an established service, including specialised techniques selected according to clinical need. Proton beam therapy is not a routine on-site Royal Marsden service and should not be assumed to be available there. If proton treatment may be appropriate, ask whether assessment and referral to another provider can be arranged, and how this would affect funding and coordination.

CAR-T cell therapy is relevant to selected blood cancers, not a general treatment for all cancers. Ask the haematology team whether an appropriate licensed or trial pathway is currently available for the specific diagnosis and an overseas-funded patient. Assessment, cell collection, manufacturing and monitoring can involve several stages. Supportive and palliative care may accompany any cancer treatment to address symptoms and quality of life.

Klinische Studien

The Royal Marsden has a broad oncology research portfolio, including early-phase drug development and later-phase studies. Around 300 active oncology trials is an indicative profile figure, not a verified current count of studies open to new participants. Some studies may be closed to recruitment or limited to particular diagnoses, age groups, biomarkers or treatment histories. Participation is not evidence that an experimental therapy is better than standard care.

International patients can ask the relevant disease team to review possible trial eligibility alongside standard treatment options. Screening may require pathology, recent scans, laboratory results and sometimes additional biopsies. Overseas residence, follow-up requirements, funding and the ability to attend frequent visits can affect feasibility. A trial may cover the investigational medicine without covering all routine care, travel or accommodation. Obtain written clarification of responsibilities and remember that eligibility can only be confirmed through formal screening.

Praktische Hinweise für internationale Patientinnen und Patienten

Start with a records-based assessment rather than booking travel for an assumed treatment. Ask which team and site would manage the case, whether further tests are needed and whether treatment abroad offers a clinically meaningful option compared with local care. A specialist review may confirm the existing plan rather than recommend a different treatment. Seek urgent local care if symptoms are worsening while a referral is being arranged.

Request a written care proposal and itemised financial estimate, including foreseeable monitoring and complications. Confirm insurer or sponsor authorisation before committing. Plan accommodation around the actual treatment site and discuss caregiver needs, fitness to fly and follow-up at home. Private referral does not itself establish eligibility for NHS-funded care.

Kontaktinformationen

Contact details below come from the hospital's own published international patient information.

Location: London, United Kingdom

Email: private.patients@rmh.nhs.uk

Phone: +44 20 7811 8111

Website: https://www.royalmarsden.nhs.uk

Languages supported: English, Arabic, Russian

Remote second opinion: Available

Always confirm current contact details on the hospital's own website before sending medical records, and never send documents to an address you have not verified.

Fragen von Patientinnen und Patienten

Which specialist team and hospital site would review my diagnosis?
What records, tissue samples and translations are needed before assessment?
What treatment do you recommend, and what alternatives are available locally?
Is the proposed treatment standard care, off-label treatment or part of a trial?
Am I eligible for any currently recruiting study as an overseas patient?
What does the estimate include, and how are complications charged?
What interpreter, accommodation and caregiver arrangements should I make?
How will follow-up and urgent problems be managed after I return home?

Häufige Fragen

How can an international patient request a referral?

Use the official Royal Marsden website to find the current private care or international patient enquiry route. Ask whether a clinician's referral is required and how to submit records securely. The hospital will need enough information to identify the appropriate specialty and assess whether it can offer suitable care. An enquiry is not confirmation of acceptance, a treatment booking or trial eligibility. Request written confirmation of the next steps before arranging travel.

Which medical records should I prepare?

Prepare a concise medical summary, pathology reports, scan reports and the actual imaging files where available. Include dates and details of previous surgery, radiotherapy and drug treatments, recent blood results, current medicines, allergies and relevant medical conditions. Molecular test results can be important for targeted treatments and trials. The team may request tissue blocks or slides for specialist review. Ask which documents need an English translation and whether translations must meet particular standards.

What should I expect about costs and payment?

Costs depend on the assessment, treatment plan, duration of care and any additional needs. Ask for a written estimate that separates consultations, diagnostic tests, hospital care, medicines and follow-up. Clarify whether professional fees are included and how unplanned admissions or complications would be billed. Insurers and sponsors may require prior authorisation. Trial participation does not automatically make all care free. Travel, accommodation, visa expenses and caregiver costs should be budgeted separately unless explicitly included.

Is language support available?

Ask the international patient or private care team what professional interpreting support can be arranged for your language, whether advance booking is required and whether charges apply. Do not assume an interpreter will be available at every appointment without notice. Interpretation is especially important for consent, treatment risks and medicine instructions. A relative may provide support, but professional interpretation can help avoid misunderstandings. Also ask whether written treatment summaries and discharge instructions can be translated.

How should I plan travel and accommodation?

Confirm the treatment site and likely visit pattern before booking accommodation, because Chelsea and Sutton are separate locations. Ask about nearby accommodation information, accessibility and whether a caregiver should stay with you. Some treatments require repeated appointments or remaining close to the hospital for monitoring. Discuss fitness to fly, insurance exclusions and visa documentation with the relevant professionals. Keep bookings flexible where possible, as clinical assessment or side effects can change the planned schedule.

Quellen

1.The Royal Marsden: official hospital, research and private care information— The Royal Marsden NHS Foundation Trust
2.Cancer treatments and clinical trials: general patient information— National Cancer Institute
3.Cancer care guidance and patient resources— European Society for Medical Oncology
4.Cancer and health systems: general information— World Health Organization

GetOnco AI fragen

Erhalten Sie persönliche Antworten zu „The Royal Marsden Hospital: Cancer Care in London“ von Ihrem KI-Koordinator für Krebsversorgung.

GetOnco AI liefert Informationen zu Bildungszwecken und ersetzt niemals den Rat Ihres Behandlungsteams.